Zimmer Biomet Financial Ratios
NYSE: ZBHHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Zimmer Biomet ratio analysis
Zimmer Biomet earned a net margin of 8.6% in FY 2025, down from 11.8% a year earlier. Gross margin was 69.7% compared with a median of 71.4% over the prior 9 years. Return on equity reached 5.6%, meaning Zimmer Biomet generated 0.06 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.59 versus 0.50 the year before, and the current ratio was 1.98. At the end of FY 2025, ZBH traded at 25.4 times earnings; across the 8 fiscal years shown, its year-end P/E ranged from 13.2 to 115.9, with a median of 25.9. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Zimmer Biomet financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 25.36 | 23.58 | 24.94 | 115.91 | 64.58 | — | 26.41 | — | 13.16 | 66.35 |
| Price / sales | 2.17 | 2.76 | 3.43 | 3.85 | 3.77 | 5.05 | 3.71 | 2.59 | 3.03 | 2.61 |
| Price / book | 1.40 | 1.70 | 2.04 | 2.22 | 2.03 | 2.54 | 2.39 | 1.82 | 2.02 | 2.07 |
| Gross margin | 69.7% | 71.5% | 71.8% | 70.9% | 71.3% | 70.2% | 71.8% | 71.4% | 72.7% | 68.9% |
| Operating margin | 13.3% | 16.7% | 17.3% | 10.0% | 12.6% | 1.4% | 14.3% | 0.4% | 10.2% | 10.7% |
| Net margin | 8.6% | 11.8% | 13.8% | 3.3% | 5.9% | -2.3% | 14.2% | -4.8% | 23.2% | 4.0% |
| Free cash flow margin | 17.9% | 16.9% | 17.5% | 16.8% | 19.9% | 17.8% | 17.3% | 20.0% | 18.3% | 18.9% |
| Return on equity (ROE) | 5.6% | 7.2% | 8.2% | 1.9% | 3.2% | -1.1% | 9.1% | -3.4% | 15.5% | 3.2% |
| Return on assets (ROA) | 3.1% | 4.2% | 4.8% | 1.1% | 1.7% | -0.6% | 4.6% | -1.6% | 7.0% | 1.1% |
| Debt / equity | 0.59 | 0.50 | 0.46 | 0.47 | 0.56 | 0.67 | 0.66 | 0.79 | 0.86 | 1.16 |
| Current ratio | 1.98 | 1.91 | 1.61 | 1.88 | 1.41 | 1.99 | 1.37 | 1.83 | 1.49 | 1.96 |
| Revenue growth | 7.2% | 3.8% | 6.5% | 1.6% | 11.4% | -23.2% | 0.6% | 1.7% | 1.8% | 27.9% |
| EPS growth | -19.9% | -9.2% | 343.6% | -42.4% | — | -112.2% | — | -120.9% | 489.4% | 96.1% |